Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 471–480 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 471

    Medicine slug
    doxazosin
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    67
    Source count
    65
    Agreement rate
    0.984615
    Recorded readings

    1. 22 hours

      Numeric value
      22
      Unit
      hours
      Source records
      64

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 64 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f67fa58-f623-4145-9e2c-98feee7ca45f (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40e47e75-6a47-323b-e054-00144ff8d46c (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2830533c-ccdf-4401-b19c-763eeb1bc0a7 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b4c974ad-cbd6-4811-ab48-461e7ffa99f7 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f4dc1a7-05e6-41d7-908c-30ce2677d87b (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d42d2691-f25d-4dfc-99d0-3286d71480a4 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:de9ab9a4-d8b8-8b36-e053-2a95a90aaa35 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57f4a953-ad23-4a44-9956-c48aa5927132 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64a19cb1-79fc-8b0b-e053-2a91aa0aaa94 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30b709d6-c438-c721-e063-6294a90abd61 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f306adae-a2fe-5477-e053-2995a90a7838 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3354196f-bbcf-4bc5-94f6-e6e8e132acb1 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:08521333-ff21-45ad-b99e-1f43d945d24d (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7991373e-8a62-47f9-b4fb-90573485af4e (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0d9df8e9-f823-4ff8-a5fe-0309dd132b04 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b364c7a8-72b5-4776-a500-400c37a72c9b (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:187bc51b-7a3a-5910-e063-6294a90aa888 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54549d19-6311-4dbb-8622-fd3e5440551a (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b887aa5-5edf-48c5-a480-dea8c35afa9d (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44bfe5d7-a56a-46f1-8ef3-ad386ab35f0f (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8de7d5ee-7f9d-447a-af76-7a7fbf3eb33d (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7e547752-a53a-4ad9-b70e-7cc2a1dd5d5d (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:46b01b1d-c48a-4c36-bf3c-bba98066166c (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b57cf33b-e0bd-54e9-e053-2a95a90a5a6a (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3d381c1-3b2f-af70-f4e6-08d6202eed25 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:71815e8f-33ed-4f36-a8ec-d4443151a9d8 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bfea0b5b-9354-490f-88ff-008134077d24 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30a6bb83-f91b-4c4f-a849-4f2be3735a0e (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0aaa68a7-f73b-46d8-860f-a76d96897489 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6fbb9ca2-e8ca-45c7-a178-b4c8dd7a9a1f (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e4758bf9-b9d4-4268-beb8-0d7e06890895 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f1dc70f6-4329-46da-8990-7bd6eec9d37d (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac4cd22b-2a03-47b6-9eed-550be278f17d (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b5d1c604-ce3b-4973-845f-9db267a945cd (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5e1f5e49-2da1-43ab-9795-228a8bcc5a82 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2f5d7d2-21aa-4921-8035-da945d3c565c (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:508b908e-8d80-422e-8ec0-2081185f4c95 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7aeaa0e1-136c-444d-b66c-7a5a96fb3022 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:277c3278-4fe2-47ac-9115-15b417325ffd (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ec06f008-37a1-4757-a3ee-0b4720912bc4 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54eeef3d-c906-37e7-e063-6294a90afca2 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ea9bb6b-a4f0-496a-b27b-4454167a4b70 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a7f589b0-eebb-48cb-912f-a4bd956e4dcb (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4fa5c2f7-cda9-56cd-622f-b3d05dc7c94b (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6c9856e-9154-f349-e053-6294a90a9f2c (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:93f2d724-5a54-4721-b04a-e46bc764607b (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion: Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d8ff659-8129-4dca-9e8f-13b97240d1e1 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:64a243e6-7056-115d-e053-2a91aa0a510f (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ef8b5534-5939-400a-ad5e-f9ceaefc4097 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ab222b7-74cc-5343-e063-6294a90a9616 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54116886-ea5e-5320-e054-00144ff8d46c (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4034fb6d-f55d-4df0-b500-d6a413591f6e (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8c0c0345-833b-4a3d-9081-da66b208d750 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b74b18f-b89a-4109-a29e-c4fa65a3c5ee (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:88efdfb0-710f-768a-e053-2995a90aede4 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2e5cd8cb-7d43-e7af-e063-6294a90a310e (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2110eec5-949d-4718-ad6d-3629e5db8a07 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:505d3c4c-5506-72cc-e054-00144ff88e88 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9b6170e7-814a-46ef-b068-cf3e6508d5e1 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2b35586-d550-3fcb-e053-2995a90a3403 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e046e0b7-f510-4318-9884-034d683864d4 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eefc47bc-c10f-49bb-8ef7-5999f798ab39 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours.

    2. 15-19 hours

      Numeric value
      15
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:355bcdce-0481-48ba-8ebd-2009106aaf77 (opens source in a new tab)

        Doxazosin label

        Version not recorded · Effective date not recorded

        The apparent elimination half-life of CARDURA XL is 15-19 hours.

  2. Projected row 472

    Medicine slug
    doxepin
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    103
    Source count
    43
    Agreement rate
    0.44186
    Recorded readings

    1. 15.3 hours

      Numeric value
      15.3
      Unit
      hours
      Source records
      19

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 19 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57efdc34-d619-e413-e063-6394a90a0e04 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:77782f36-d120-4c3d-bebd-c8b0f4749d98 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:399866d5-3fa6-46d0-9c62-492d5997bc4f (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:06e79a65-1455-804e-e063-6394a90a2f3d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:29b3bf98-2c57-4d87-b5eb-5232e46dc639 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c42333f8-1add-4f33-9458-6fe4436874a1 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t1/2) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00ef7d0b-4bb9-cd5b-e063-6294a90abc35 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc3b0401-df4a-46a2-a29b-3d70e72aa88b (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3eac8e4-224e-4b7b-81d3-071301f914fa (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3377541d-db46-4fd9-9a4b-faa5f6108e67 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1bec1223-5239-4eb6-a9e8-62444106d2c0 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12edd5c6-c863-b83a-e063-6294a90a2f36 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:207bb11e-6029-4506-92d2-2d8a776b9408 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:96086fd8-8fa3-4a2b-ac12-fe1a3ad4f384 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a8c56ab-5dd1-4e1a-b26a-3af45b961dd0 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a9c2159-e89e-47e4-b91c-ac5560607a2d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b198ade7-fe78-437e-82b4-693dfe45ab51 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:554ab06f-6420-42b3-89d1-d97554c237d8 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5b4dba99-6b66-4091-94f1-bf5f021c688a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Less than 3% of a doxepin dose is excreted in the urine as parent compound or nordoxepin.The apparent terminal half-life (t ½) of doxepin was 15.3 hours and for nordoxepin was 31 hours.

    2. 8 to 24 hours

      Numeric value
      8
      Unit
      hours
      Source records
      19

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 19 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:89ed6385-cf6a-458e-81ea-c7f3fead41c5 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03cef3a6-a63d-4082-a491-451b24227d9d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f7d7b5-b747-49ac-9bf0-1510987b0291 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54616c93-2325-4719-e063-6394a90a3910 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b1f0144-65d8-451f-8054-6be1675f102c (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f350afed-120b-422d-9e6e-3aaa0f72a5fb (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4920401a-cde5-404b-82aa-c3c0e8911065 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:46be666a-fb9f-42a5-a55c-ea15fd5538c9 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1496dfc1-de50-471c-be87-1f1e2b70ab5a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ecd3b43-b5f1-4cf4-af36-eb214c1a3c60 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1533343b-f1ed-4c3a-bb36-23a748452b05 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3c242dd-426e-4c69-8f21-2645361d5f27 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:21dc77be-23af-4a1f-b189-dfee8ae2f894 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2297f75-c498-419b-aa29-057271313a7f (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fdaf3bd7-c456-40bd-8bc3-2b67eb1846c8 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d2a91b99-513d-4894-ad6d-02d2028a2290 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ede17e6-19e9-455c-ad16-8029a590735c (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4f84a4-07a1-4d0e-85f5-dcd43b236a42 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1513c98c-e7ef-4009-b932-6757048bb86a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Elimination In healthy volunteers, the plasma elimination half-life of doxepin ranged from 8 to 24 hours (mean 17 hours).

    3. 28 to 52 hours

      Numeric value
      28
      Unit
      hours
      Source records
      5

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 5 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4a4eab1c-8e19-48f5-9216-09ab83eaa5f8 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Desmethyldoxepin has a half-life that ranges from 28 to 52 hours and is not affected by multiple dosing.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca53346b-8ab3-4722-98f6-cf272706d3fa (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Desmethyldoxepin has a half-life that ranges from 28 to 52 hours and is not affected by multiple dosing.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd8d5edd-7b08-4061-86e6-c4179da89c0d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Desmethyldoxepin has a half-life that ranges from 28 to 52 hours and is not affected by multiple dosing.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b4771ea7-c19b-4182-bb23-c1473ab583fa (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Desmethyldoxepin has a half-life that ranges from 28 to 52 hours and is not affected by multiple dosing.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f302247-525e-4acc-852b-00eb1d79af4b (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Desmethyldoxepin has a half-life that ranges from 28 to 52 hours and is not affected by multiple dosing.

  3. Projected row 473

    Medicine slug
    doxepin
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    103
    Source count
    19
    Agreement rate
    1
    Recorded readings

    1. 76%

      Numeric value
      76
      Unit
      %
      Source records
      19

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 19 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:89ed6385-cf6a-458e-81ea-c7f3fead41c5 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03cef3a6-a63d-4082-a491-451b24227d9d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f7d7b5-b747-49ac-9bf0-1510987b0291 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54616c93-2325-4719-e063-6394a90a3910 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b1f0144-65d8-451f-8054-6be1675f102c (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f350afed-120b-422d-9e6e-3aaa0f72a5fb (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4920401a-cde5-404b-82aa-c3c0e8911065 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:46be666a-fb9f-42a5-a55c-ea15fd5538c9 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1496dfc1-de50-471c-be87-1f1e2b70ab5a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ecd3b43-b5f1-4cf4-af36-eb214c1a3c60 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1533343b-f1ed-4c3a-bb36-23a748452b05 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3c242dd-426e-4c69-8f21-2645361d5f27 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:21dc77be-23af-4a1f-b189-dfee8ae2f894 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2297f75-c498-419b-aa29-057271313a7f (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fdaf3bd7-c456-40bd-8bc3-2b67eb1846c8 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d2a91b99-513d-4894-ad6d-02d2028a2290 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ede17e6-19e9-455c-ad16-8029a590735c (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4f84a4-07a1-4d0e-85f5-dcd43b236a42 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1513c98c-e7ef-4009-b932-6757048bb86a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        The protein binding for doxepin was approximately 76%.

  4. Projected row 474

    Medicine slug
    doxepin
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    103
    Source count
    19
    Agreement rate
    1
    Recorded readings

    1. 3.5 hours

      Numeric value
      3.5
      Unit
      hours
      Source records
      19

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 19 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57efdc34-d619-e413-e063-6394a90a0e04 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:77782f36-d120-4c3d-bebd-c8b0f4749d98 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:399866d5-3fa6-46d0-9c62-492d5997bc4f (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (Tmax) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:06e79a65-1455-804e-e063-6394a90a2f3d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:29b3bf98-2c57-4d87-b5eb-5232e46dc639 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c42333f8-1add-4f33-9458-6fe4436874a1 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00ef7d0b-4bb9-cd5b-e063-6294a90abc35 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc3b0401-df4a-46a2-a29b-3d70e72aa88b (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (Tmax) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e3eac8e4-224e-4b7b-81d3-071301f914fa (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3377541d-db46-4fd9-9a4b-faa5f6108e67 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1bec1223-5239-4eb6-a9e8-62444106d2c0 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Absorption The median time to peak concentrations (Tmax) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:12edd5c6-c863-b83a-e063-6294a90a2f36 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:207bb11e-6029-4506-92d2-2d8a776b9408 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (Tmax) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:96086fd8-8fa3-4a2b-ac12-fe1a3ad4f384 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a8c56ab-5dd1-4e1a-b26a-3af45b961dd0 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a9c2159-e89e-47e4-b91c-ac5560607a2d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (Tmax) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b198ade7-fe78-437e-82b4-693dfe45ab51 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:554ab06f-6420-42b3-89d1-d97554c237d8 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5b4dba99-6b66-4091-94f1-bf5f021c688a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Pharmacokinetics Absorption The median time to peak concentrations (T max ) of doxepin occurred at 3.5 hours postdose after oral administration of a 6 mg dose to fasted healthy subjects.

  5. Projected row 475

    Medicine slug
    doxepin
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    103
    Source count
    19
    Agreement rate
    1
    Recorded readings

    1. 20 L/kg

      Numeric value
      20
      Unit
      L/kg
      Source records
      19

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 19 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:89ed6385-cf6a-458e-81ea-c7f3fead41c5 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:03cef3a6-a63d-4082-a491-451b24227d9d (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55f7d7b5-b747-49ac-9bf0-1510987b0291 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54616c93-2325-4719-e063-6394a90a3910 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b1f0144-65d8-451f-8054-6be1675f102c (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f350afed-120b-422d-9e6e-3aaa0f72a5fb (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4920401a-cde5-404b-82aa-c3c0e8911065 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:46be666a-fb9f-42a5-a55c-ea15fd5538c9 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1496dfc1-de50-471c-be87-1f1e2b70ab5a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ecd3b43-b5f1-4cf4-af36-eb214c1a3c60 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1533343b-f1ed-4c3a-bb36-23a748452b05 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3c242dd-426e-4c69-8f21-2645361d5f27 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:21dc77be-23af-4a1f-b189-dfee8ae2f894 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2297f75-c498-419b-aa29-057271313a7f (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fdaf3bd7-c456-40bd-8bc3-2b67eb1846c8 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d2a91b99-513d-4894-ad6d-02d2028a2290 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1ede17e6-19e9-455c-ad16-8029a590735c (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3d4f84a4-07a1-4d0e-85f5-dcd43b236a42 (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1513c98c-e7ef-4009-b932-6757048bb86a (opens source in a new tab)

        Doxepin label

        Version not recorded · Effective date not recorded

        Distribution The mean apparent volume of distribution for doxepin was approximately 20 L/kg.

  6. Projected row 476

    Medicine slug
    doxercalciferol
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    8
    Source count
    8
    Agreement rate
    1
    Recorded readings

    1. 32 to 37 hours

      Numeric value
      32
      Unit
      hours
      Source records
      8

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 8 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7d07fa4f-f2a2-4c2b-86bf-c0a4691c1a0a (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH) 2 D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f0d79a1b-c7fb-4521-941a-5d6c2fd50170 (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH) 2 D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f472b60a-e6f5-1a87-3eff-539d6287d285 (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH) 2 D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ed2f592-27a7-4c10-a18a-21a3f221d3b1 (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH) 2 D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:943a3f95-842c-455f-9050-3d1c3971c6f8 (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH) 2 D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81a30e4b-be74-41d6-8277-b4f0ea5c15bc (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH) 2 D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3376536b-043d-478a-b129-7ce11ec94e3e (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH) 2 D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:356fb38a-791c-48f0-9312-6203ae57d80c (opens source in a new tab)

        Doxercalciferol label

        Version not recorded · Effective date not recorded

        Elimination The mean elimination half-life of 1α,25-(OH)2D 2 after an oral dose is approximately 32 to 37 hours with a range of up to 96 hours.

  7. Projected row 477

    Medicine slug
    doxorubicin
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    28
    Source count
    13
    Agreement rate
    0.538462
    Recorded readings

    1. 20 hours

      Numeric value
      20
      Unit
      hours
      Source records
      7

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 7 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74b14803-afc8-4a2e-ba92-43f1a72025eb (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The terminal half-life is 20 hours to 48 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:33ddfdb1-b4bc-464d-a186-49c4b156279f (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The terminal half-life is 20 hours to 48 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d928625e-c1ef-4f25-8d25-764c8c6aab67 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The terminal half-life is 20 hours to 48 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1fd148fb-0fbc-4b6f-b790-23546fb46a71 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The terminal half-life is 20 hours to 48 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d31d7f58-66d0-4826-b6b5-5914c031965f (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The terminal half-life is 20 hours to 48 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae80bd3a-b99a-4e01-a444-b9d05687f00e (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The terminal half-life is 20 hours to 48 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00634b2b-4e48-4178-8877-28582af894ad (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The terminal half-life is 20 hours to 48 hours.

    2. 20 to 48 hours

      Numeric value
      20
      Unit
      hours
      Source records
      6

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 6 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f62aa88d-1e25-4049-87ec-99d42edd1d31 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The distribution half-life is approximately 5 minutes, while the terminal half-life is 20 to 48 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e0349f98-42fa-4003-b6d8-a1db1401b0ef (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Distribution The initial distribution half-life of approximately 5 minutes suggests rapid tissue uptake of doxorubicin, while its slow elimination from tissues is reflected by a terminal half-life of 20 to 48 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f71f79a-4f14-472d-b982-e28c3ce8f972 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The distribution half-life is approximately 5 minutes, while the terminal half-life is 20 to 48 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:971de64b-ff09-4370-afd9-6eb1093ad27d (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The distribution half-life is approximately 5 minutes, while the terminal half-life is 20 to 48 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6bcde92b-e584-4919-866a-68847ea201ba (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The distribution half-life is approximately 5 minutes, while the terminal half-life is 20 to 48 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:36924f82-6c05-4989-9f41-a398c0ad48e6 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        The distribution half-life is approximately 5 minutes, while the terminal half-life is 20 to 48 hours.

  8. Projected row 478

    Medicine slug
    doxorubicin
    Compared field
    proteinBinding
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    28
    Source count
    15
    Agreement rate
    1
    Recorded readings

    1. 70%

      Numeric value
      70
      Unit
      %
      Source records
      15

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 15 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fbc48fa5-0bfb-4957-b13c-a56bb7a13b56 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55889588-c5f1-d9bc-e063-6294a90a5791 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8e001f5-441c-47cd-86f6-5d5e3de16bc0 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f8eb9a1-74d0-47fd-94b8-a65b29006521 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b8b66e93-0813-4876-b291-8d7c36a99807 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c8eb4784-36e0-483f-9e5d-af0552e49bb5 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9cb8a8d-944f-4fe1-bfba-c55904a79fda (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0885dddf-727e-4692-92dd-a26c69cc278d (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ada390ce-50ea-4de5-be58-5b03caf33c23 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:917eddf9-1d3f-4abe-8c81-d33b066e5bae (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of DOXIL liposomal infusion has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15a84bd6-b565-4722-bb92-e4c919620a90 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f1a12eb5-5bdc-45f4-843e-0c971535b184 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ddf55319-bf62-4ec7-8be2-ef97188837c4 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6508535-e7a7-4e50-8d0c-43deda8d0d08 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of doxorubicin hydrochloride liposome injection has not been determined; the plasma protein binding of doxorubicin is approximately 70%.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        Plasma protein binding of DOXIL liposomal infusion has not been determined; the plasma protein binding of doxorubicin is approximately 70%.

  9. Projected row 479

    Medicine slug
    doxorubicin
    Compared field
    volumeOfDistribution
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    28
    Source count
    15
    Agreement rate
    0.6
    Recorded readings

    1. 700 to 1100 L

      Numeric value
      700
      Unit
      L
      Source records
      9

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 9 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55889588-c5f1-d9bc-e063-6294a90a5791 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that Doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8e001f5-441c-47cd-86f6-5d5e3de16bc0 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that Doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0f8eb9a1-74d0-47fd-94b8-a65b29006521 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b8b66e93-0813-4876-b291-8d7c36a99807 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c9cb8a8d-944f-4fe1-bfba-c55904a79fda (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that Doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0885dddf-727e-4692-92dd-a26c69cc278d (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that Doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:917eddf9-1d3f-4abe-8c81-d33b066e5bae (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that DOXIL liposomal infusion is largely confined to vascular fluid.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f1a12eb5-5bdc-45f4-843e-0c971535b184 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1c153e9e-4cf2-4ac7-9cf9-16f9b48d7dce (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that DOXIL liposomal infusion is largely confined to vascular fluid.

    2. 700 to 1,100 L

      Numeric value
      700
      Unit
      L
      Source records
      6

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 6 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fbc48fa5-0bfb-4957-b13c-a56bb7a13b56 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1,100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c8eb4784-36e0-483f-9e5d-af0552e49bb5 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1,100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ada390ce-50ea-4de5-be58-5b03caf33c23 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1,100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:15a84bd6-b565-4722-bb92-e4c919620a90 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1,100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ddf55319-bf62-4ec7-8be2-ef97188837c4 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1,100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6508535-e7a7-4e50-8d0c-43deda8d0d08 (opens source in a new tab)

        Doxorubicin label

        Version not recorded · Effective date not recorded

        In contrast to doxorubicin, which displays a large volume of distribution (range 700 to 1,100 L/m 2 ), the small steady state volume of distribution of liposomal doxorubicin suggests that doxorubicin hydrochloride liposome injection is largely confined to vascular fluid.

  10. Projected row 480

    Medicine slug
    doxycycline
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    234
    Source count
    230
    Agreement rate
    0.7
    Recorded readings

    1. 18-22 hours

      Numeric value
      18
      Unit
      hours
      Source records
      161

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 161 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5fdc01c3-c62f-40cf-8351-91cbcc43d379 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:61195fc6-3fa7-4203-b526-477b48395856 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:86c1f165-af79-4f01-ab61-3bdbce24cd0d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b0894010-39bd-459f-8563-cf83343105ee (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:860a1566-5857-ed88-e053-2991aa0ae2a4 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7ce80f6e-3c0d-4978-b626-5fd3f3ff349e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19d93cd3-6ac6-4e5d-8e7e-1a48799df3cf (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a569ba80-ffea-40b2-9fbe-a42810b1fccb (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53deb73a-c828-46e8-994e-d84e3bf8dc98 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:45c4b584-b7e2-4e91-a93d-aff14feb606f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0aaa4ff7-7fba-4a40-9b49-82e4da68a48f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a915c50-6fce-45e6-9554-677bb09a868d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:acb84610-5e26-4b0c-89e5-42bc0f8fa00d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe6985d2-37f7-4277-94a9-f7125b4b3fd7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:35aa295e-ff1b-453b-8eeb-65bbeda3baa5 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f0fbf63a-e75c-40cf-b2e9-429deaac899d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c8194d6e-c407-465e-a342-4d2d9756dfc4 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca63aa91-519d-429f-adfc-a4ec45367294 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b752ea66-3144-4f78-96fe-a5f4d92740a7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1dd7a94e-bf29-4f07-9476-ac8d1f9ab565 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f33ae6f5-bdb6-4c15-9e62-6180433bb1fb (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0fdc3d87-8819-4c2c-e063-6394a90a687b (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5f02688-cbba-4d9b-e053-2995a90ad1ba (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1b403f4b-1c61-3991-e063-6394a90ae4f2 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9b52e0a7-f024-4d8a-a59e-374946e60b44 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:051654c7-8ba6-44f2-842c-72f515e9b32d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ccf9708a-ed3b-4786-b3a6-e96125b2f9d5 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50617adc-8528-414d-bb6c-78887d404983 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6d1f7b0f-b71d-4cee-803b-fe418d000c9c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f523294-e62b-4da5-8799-047d4bed966f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c96d3986-9d92-4ec4-a319-a50aeb2f4fe7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f31e69fc-e513-40e4-91b5-22ccf1ed9437 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6e3d0691-c071-441c-9b00-22a380305066 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fad03768-f1d2-459f-965e-0ec29f189f1f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1401d590-0967-4c6b-b52b-a83e9f6df097 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2696f799-7902-4239-807a-9ae85a5d0f1d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b256babb-1bba-4b0c-8837-d13ba3af7659 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd7672c9-b10f-4ea1-9000-ef3e3faa10db (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2161675-505c-3d65-e053-2995a90aa644 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed95709e-2a1a-4deb-88bd-5b99f02b7a26 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9798c4de-8af7-41c4-acc2-1e9775194297 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7f882f1a-fe75-4592-9df5-f0e4bf1d232e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:65cac0b6-3550-48cf-bffa-cf42443c2731 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:52ba329a-8cb3-cf30-e063-6394a90aa0dc (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f7f6dc0d-cf8f-50b5-e053-6294a90a9e59 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0a18d4c7-9484-4d3e-b61b-e81fe63fefec (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Specific Populations Patients with Renal Impairment Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db53637e-16ac-41b0-b9d5-553471405d64 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b8486639-7eb9-4610-9cd4-0e922045d592 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4dc319c1-b7ef-40e4-9e66-fb24cfdefea8 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bdacaaa7-b46e-ee0c-e053-2a95a90aea3c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df44c686-de34-487a-8741-a0a12993cab2 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5ee43b2-d6ca-4819-a3d7-07f8421015d7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Specific Populations Patients with Renal Impairment Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cec4368f-2852-443d-9d6f-7ba95807021b (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b612d2f5-b703-47f0-b5eb-b66a7aeed577 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cd2ab9b8-9619-4199-8a5d-83377b3274d1 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Specific Populations Patients with Renal Impairment Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:878a1cf9-31a9-425b-910d-042ed91e98d5 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a3b79e8-f14c-4b44-9d3e-3c92a82269bd (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a7b754e2-a028-469d-ba95-8412ef03ab0a (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a2df1a8c-7a22-462d-830a-04e6ac5a912f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5e96d473-63dd-4446-88cf-eef2cd3339f0 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a84d7562-08bf-417f-a599-ba0d17c55232 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:716dccec-7480-44dd-91b9-249ae2c25088 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:30b041a0-8f5f-4d9f-b11b-106f7432955b (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b402587-8ecc-4fea-83ad-8071345b6356 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bed39bae-64c2-44b4-9c95-682ead4e6738 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0faee97d-2707-48fe-a739-143cd1a1c4e3 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7772e702-20b3-473a-8bd5-9c7c92e753c6 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1a3c713f-bc4f-4848-e063-6394a90a0272 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00b2aa98-dea2-90c3-e063-6294a90a35d6 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:548d4218-2feb-8716-e063-6394a90afbe3 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b8b76aaa-575b-497f-b854-c42bc992c784 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3af9348c-a98b-4059-a5ef-4229e2b33af0 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2946fc05-78e5-4669-85d1-3a3979eceae0 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c29f716-bdb0-437d-92a4-d856b87db976 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c0206e91-d87f-311c-80dc-aad543d001e8 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3ae4ca12-be39-46b9-bc4c-f8356776c175 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Specific Populations Patients with Renal Impairment Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4ec4c8ca-ce83-4948-8626-21eb82ae5c19 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f309ccbb-b68a-3190-e053-2995a90a0ad4 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49ecbf95-58e8-4f3c-b5d5-650a15d866cb (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:325d5331-d48e-1bc4-e063-6394a90a65b9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6a5780a9-4548-427c-972a-ef49fdcbc84d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b56dffde-1334-f5a0-e053-2a95a90a717c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b4f2ab4f-c32b-6435-e053-2995a90a69b6 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79f3c026-7687-4a11-8d2e-03493531d3bf (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:24c8472a-dd07-4f84-8bea-20a3f178d119 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b988f851-cc06-4570-9706-cf65d370bd8e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c2b08332-3256-4658-965a-ede3d973a388 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Specific Populations Patients with Renal Impairment Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0994d23a-f9e4-4c33-ba44-a1f4ae4a312c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bcc95094-80ed-4023-b2a6-955a4810bfbe (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0106a3d3-db4d-f6ee-e063-6294a90a25e9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2305ab4a-7d08-41f6-9c39-c9b6835be389 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5ed9293-15f8-ecfa-e053-2a95a90ab6a4 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:09d19663-a8b9-0c3f-e063-6394a90aa446 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5571acf-3284-4559-8cc0-b4856ac6d94d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa3fbb09-b830-60c5-e053-6394a90a4165 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e726157e-ce44-4df3-8161-7016700dd751 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4aae81f-0219-450f-aa60-953964f74172 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6f530f28-8c10-41dc-818f-1aef2306bde5 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6e06e73c-b777-4a2d-988f-b009f2fc34d1 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f9277bb8-982d-444d-9325-35d5c53a2d35 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Specific Populations Patients with Renal Impairment Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ad2b85f-2479-c7cd-e063-6294a90acca1 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2deeee4f-b342-a178-e063-6394a90af897 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10988250-b267-4f10-b264-5f127cc1ae18 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cf95b2ca-2cf8-49a8-8e3a-f9b0f5b2072c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3e7cf78f-3b48-4614-9fa4-c6d1e0c05a35 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d3c0b756-30ba-4ef9-a178-fd785d720373 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c36798a1-b865-4e94-9905-5af024a9e250 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bea36ec9-f7fd-4295-bfbd-0228cffcddd7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10b8bf71-4311-41e8-a891-bab8bc86863f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:25a92544-1421-4ccb-a49c-11742851f214 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ecab47ea-d7b9-515d-e053-2995a90adc46 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:65b3a0e2-32a5-436a-b805-854fbffcb611 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd672959-014f-8300-e053-6394a90a5ec5 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6624a43a-28ff-4d55-b5dd-1e805bfa8778 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cff08863-7156-49d0-abbd-8f9274302886 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44ac5de1-c0c6-4d58-9a49-b2dae60ea921 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Specific Populations Patients with Renal Impairment Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0b251a58-30d8-dfec-e063-6294a90a3b45 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1df9e905-d2e7-4a5a-8bd6-43f4850ba900 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:214e5a5c-7f3e-478b-93d3-1713de9e7672 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2151005-fb4a-485d-88ad-b44c4594d579 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3303b423-b270-495b-9360-e43144fcf6f2 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fd58dbe5-aab2-4378-b054-d5c60d87074e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2aa835bd-6fac-46b8-9716-9622fb550c8f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51d245a3-ef51-474a-bc91-377d5f42dde3 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:763997f0-b35c-43cb-a792-3e0bae589536 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f9a9a558-4063-4aa7-9191-3875c97cf49a (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      127. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fbd0a22f-b365-c0a2-e053-6394a90a1e07 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      128. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b70a3a12-76a2-4558-bf2c-eaa38a9ba0a0 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      129. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3a85933f-bd73-4ad7-968d-c90cb7c7a60c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      130. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:88c429a1-351d-432e-b69b-d7a0afca482a (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      131. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e7c14a8e-c713-4f03-94e8-1ec9ae077d4d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      132. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:429813b4-0223-4d85-a844-b1227ff63b1e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      133. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe8cd3c6-36d6-4d92-bc5c-833cd6f9cb32 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      134. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e24a3292-0d4f-4692-8cf7-a82bd19e5932 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      135. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1c998ca8-1df6-4b3c-9533-f4500cc1079a (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      136. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2993ac3d-0ec4-4230-858e-9fd00063cf57 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      137. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4164f6b7-5ebd-4f5f-a536-9a37b2e0562c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      138. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6e587d8d-1a82-4dfa-acea-88704d408f2f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      139. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5b4390ed-a0ec-4ef8-864c-8a33a83653f9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      140. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6772807d-a39e-47ce-9584-a08e7f8940d2 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      141. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:131af052-0c4f-4a61-ae9a-e6165ae09076 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      142. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:83243f78-b984-46a4-a88a-c6a15c217b90 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      143. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:43ceb0ee-268a-424c-a6a8-88e824c5ed04 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      144. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dd70368b-1949-4833-9d1e-f9f4cdacd9f3 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      145. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5bebf320-1395-43b9-9404-fe479d70b240 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      146. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:53ff9f7e-0db0-c841-d334-4cf31f658828 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      147. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d421b771-de88-4769-949f-8a24baa69c25 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      148. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a34fbbc7-09dc-42d6-a075-f4ea8f170ba7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      149. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:214a9cfe-a522-4022-81d4-e59f447401fe (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      150. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:02f87c60-8425-1a1e-e063-6294a90a0c94 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      151. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e567b431-53fe-4e27-9b05-bf6eeb8abb51 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      152. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e0e80435-1b6a-4361-8c8a-e432f8f23a1b (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      153. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4fa26176-a730-48ed-9659-e2f64212f418 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in the serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      154. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e38f3cd2-47e5-438f-bbe3-50b578360f74 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18-22 hours) in individuals with normal and severely impaired renal function.
      155. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a707c9e3-00eb-e832-e053-2a95a90a5f58 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      156. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:104cac0f-7c99-4faf-ba08-0159ed767a3e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      157. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9cbd8699-e2c2-40d4-8797-e676f2a10eb2 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      158. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f18daceb-33a3-4931-9be7-ecd6356cc119 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      159. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:44f2fdde-cf84-6f42-e063-6394a90af94e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.
      160. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:98bf51e7-01f8-e3f7-e053-2995a90a42f0 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18–22 hours) in individuals with normal and severely impaired renal function.
      161. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3fb9f5ad-90a2-4858-bc34-f800d8b2fa90 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 to 22 hours) in individuals with normal and severely impaired renal function.

    2. 16.33 hr

      Numeric value
      16.33
      Unit
      hours
      Source records
      47

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 47 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa1da527-7a0f-8ed6-e053-6394a90a1b62 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        .95 0.37 0.15(μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:adc6ba78-8dd7-47af-a7b4-c2215557696b (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:829dbd3d-5c2b-47b8-96a5-423af78c93b9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bcc65910-30d8-4807-ab61-607a56382924 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d27c58a1-5c99-4007-9bc6-ad9b6fb56db8 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        .95 0.37 0.15(μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa2d9328-b688-47af-8c4d-dc328cf35392 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4b170180-21f4-4ee5-9e81-1607ab52cfca (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2a07049d-3950-d293-e063-6294a90a4450 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.6 hr (± 1.1 sd) Elimination Rate Constant 0.049 per hr (± 0.03 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dfef600c-bceb-fbc9-e053-2a95a90ae6c0 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f989cc1-48ae-41bb-b297-2f8c83760b6d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fef9580d-8850-4cbb-89eb-2b4d40ee59c9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b3b3c48-eb60-400c-bdfe-50635a136c90 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (µg/mL) Average Observed Values Maximum Concentration 3.61 µg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3b9888a2-ca16-43f7-ab6d-f03188ec2c0d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d9388b32-dcb8-4dff-8a35-8fccb31bd1f8 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.6 hr (± 1.1 sd) Elimination Rate Constant 0.049 per hr (± 0.03 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31512ece-cb16-2a9a-e054-00144ff88e88 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Halflife 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3fbf4bb8-036e-41d3-9628-476fc05ddd31 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:02aa8731-d40f-43d8-8b63-a79a0503f8db (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04de98f3-33a2-48ba-85b5-9fac867524b7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        .95 0.37 0.15(μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:57f97f68-11fb-4900-9efb-ca3b00818d8e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b83c4c4b-2885-43e7-b1c9-0b3bbf75528d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f91373f2-c57b-f1f1-e053-6294a90a7bdd (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:112c35d6-a397-45de-a57a-6e687cb27b4f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (µg/mL) Average Observed Values Maximum Concentration 3.61 µg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dedebcb4-3c3f-4487-a488-36af12640c92 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6512bf22-c211-4127-a8c8-2419656580f6 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5f22094e-9297-4d1b-a37c-7846481b321e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d77e2a9c-c536-4e66-b87a-40b085737699 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.6 hr (± 1.1 sd) Elimination Rate Constant 0.049 per hr (± 0.03 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f2f1ee15-9323-1263-e053-2995a90a01fa (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (µg/mL) Average Observed Values Maximum Concentration 3.61 µg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e49f8ff9-af7a-47eb-929b-238cff381c03 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        .95 0.37 0.15(μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:55873d3e-09c4-4726-acfe-5da581589575 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9e710113-f25e-46fb-8327-7a8e649613a2 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6aab6fee-791e-4141-b55f-685ec9d8712a (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        .95 0.37 0.15(μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8224b9c5-5c4b-4dda-bc58-47b6604c2884 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c707566b-dbc7-4dac-bad1-952f2f4d6845 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        .95 0.37 0.15(μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3ba6c30-ada3-4a57-9ff8-30558202b9aa (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Halflife 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bc321932-b600-4659-a499-1853991b4ab9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c7795c9-9e4e-477a-ad9f-01e4c55c06b6 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e9997efa-9ad8-3870-e053-2a95a90a1ac3 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3dfa486c-4665-4882-93ac-9259708f899c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.95 0.37 0.15 (μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.6 hr (± 1.1 sd) Elimination Rate Constant 0.049 per hr (± 0.03 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4999bbd9-44ed-4749-9730-be2337bdf490 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5b28a41-db12-af7c-e053-2995a90ace09 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Halflife 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f3319f4f-b535-da12-e053-2995a90ac00f (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:595470f9-2004-c378-e063-6294a90a3415 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6285181d-e34d-4def-abe6-2c41254ada75 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        .95 0.37 0.15(μg/mL) Average Observed Values Maximum Concentration 3.61 μg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2bcde264-5f6f-47f6-ae2e-1b7010deacf7 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        95 0.37 0.15 (µg/mL) Average Observed Values Maximum Concentration 3.61 µg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b46208a2-5072-4df5-b2af-379f865545d2 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        1.62 0.95 0.37 0.15 Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00ea3641-18da-4a6f-a779-e16075464d2b (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-Life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7028b7f9-21cd-4c8e-97aa-a3e7d849939b (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        0.37 0.15 (mcg/ mL) Average Observed Values Maximum Concentration 3.61 mcg/mL (± 0.9 sd) Time of Maximum Concentration 2.60 hr (± 1.10 sd) Elimination Rate Constant 0.049 per hr (± 0.030 sd) Half-life 16.33 hr (± 4.53 sd) Excretion of doxycycline by the kidney is about 40%/72 hours in individuals with normal function (creatinine clearance about 75 mL/min).

    3. 18 hours

      Numeric value
      18
      Unit
      hours
      Source records
      11

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 11 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:861b71f3-37e8-4596-838c-c8dad8ed5ff4 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Doxycycline is eliminated with a half-life of approximately 18 hours by renal and fecal excretion of unchanged drug.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ec4535a1-69f0-40a2-bcba-11afc75c721d (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Doxycycline is eliminated with a half-life of approximately 18 hours by renal and fecal excretion of unchanged drug.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:942ab6dd-e355-41da-b139-72cc8b7a2667 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Doxycycline is eliminated with a half-life of approximately 18 hours by renal and fecal excretion of unchanged drug.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b3294889-e8f8-42f1-9bd0-13d87572997a (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Doxycycline is eliminated with a half-life of approximately 18 hours by renal and fecal excretion of unchanged drug.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:95ba4d68-2519-4edd-b9a2-5cd2fd00b250 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in serum half-life of doxycycline (range 18 hours to 22 hours) in individuals with normal and severely impaired renal function.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bff3f426-44fc-4dbf-96df-df44011103e8 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        It is variously reported that between 29% and 55.4% of an administered dose can be accounted for in the urine by 72 hours. 5,6 Half-life averaged 18 hours in subjects receiving a single 20 mg doxycycline dose.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:294c6fc3-e7ca-46ea-b062-a27dd7b0bc97 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        It is variously reported that between 29% and 55.4% of an administered dose can be accounted for in the urine by 72 hours. 5,6 Half-life averaged 18 hours in subjects receiving a single 20 mg doxycycline dose.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b3cd7b44-db40-4ce5-895e-d4c85a0068ae (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Doxycycline is eliminated with a half-life of approximately 18 hours by renal and fecal excretion of unchanged drug.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9f00b2c9-e628-4265-8530-3258dd3cdcd5 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Studies have shown no significant difference in the serum half-life of doxycycline (range 18 hours to 22 hours) in individuals with normal and severely impaired renal function.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7c33c1b8-100e-4df8-be8d-de3eed7ced94 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Doxycycline is eliminated with a half-life of approximately 18 hours by renal and fecal excretion of unchanged drug.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:49f82130-6f8a-412c-b625-e75906e74675 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        It is variously reported that between 29% and 55.4% of an administered dose can be accounted for in the urine by 72 hours. 5,6 Half-life averaged 18 hours in subjects receiving a single 20 mg doxycycline dose.

    4. 21.2 hours

      Numeric value
      21.2
      Unit
      hours
      Source records
      11

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 11 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81c5a7fc-3fe0-40b2-bae0-c79eb0b27697 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline capsules.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0e6b3e17-aeee-4910-8e94-c7ac925b9cca (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of Doxycycline .
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7fb99e0c-10f6-2924-7940-84e52e7e2a36 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:99305d9a-d058-45d6-8dec-19308b1fc5a9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline capsules.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10aca485-850b-4c82-bb7e-5fac2d7a62ce (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline capsules.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a28cce1-4805-b3d1-4484-e7a49c597660 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a50e953d-447b-4b66-b567-04586174d3f9 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:8e78dc54-8322-435d-8879-4bfe37f1b98c (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a894f4be-19e5-4785-8d0b-5e0d5626300e (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline capsules.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa15c93a-ff4c-447a-8a21-96da506d8997 (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of ORACEA.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3dd8c11c-aa52-9e22-e063-6294a90a5cbd (opens source in a new tab)

        Doxycycline label

        Version not recorded · Effective date not recorded

        Terminal half-life averaged 21.2 hours in subjects receiving a single dose of doxycycline.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=470

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy